Latest News about BMY
Recent news which mentions BMY
‘Millions of women suffering in silence’: Female workers want menopause benefits, so why are they so rare?
June 02, 2023
From MarketWatch
3 Top Stocks That Just Went on Sale
June 01, 2023
From Motley Fool
From Benzinga
Bristol Myers' CAR T Cell Therapy Shows Deep, Durable Efficacy In Blood Cancer Patients
May 26, 2023
Tickers
BMY
From Benzinga
Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting
May 25, 2023
From Benzinga
Quant Ratings Updated on 119 Stocks
May 23, 2023
From InvestorPlace
From Benzinga
From Benzinga
Pfizer CEO Fires Back On US Drug Pricing Reforms: 'Negotiation with a Gun to Your Head'
May 12, 2023
From Benzinga
From Motley Fool
Tickers
BMY
From Motley Fool
$100,000 Salaries No Longer Enough — Majority Living Paycheck To Paycheck With No Savings
May 09, 2023
From Benzinga
From Motley Fool
Tickers
BMY
From Motley Fool
Insiders Selling Zoom Video Communications, Bristol-Myers Squibb And This Footwear Manufacturer
May 05, 2023
From Benzinga
7 Best Dividend Stocks to Buy Now in May 2023
May 03, 2023
From Motley Fool
From Motley Fool
From Benzinga
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
May 01, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 27, 2023
From Benzinga
Bristol Myers Squibb Posts Lower Q1 Sales As Revlimid Generic Erosion Bites, Chairman & CEO Giovanni Caforio To Step Down
April 27, 2023
Tickers
BMY
From Benzinga
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
April 27, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.